Multimodal prehabilitation enhances innate antitumor immunity via NK cell recruitment
Feng, L.; Gordon, B.; Su, X.; Brassard, A.; Dhoparee-Doomah, I.; Leo, S.; Awasthi, R.; Bourdeau, F.; Giannias, B.; Gill, H.; Minnella, E.; Ferri, L.; Najmeh, S.; Spicer, J.; Carli, F.; Cools-Lartigue, J.
Show abstract
BACKGROUNDWhile the clinical benefits of multimodal prehabilitation in cancer patients are well defined, the underlying immune modulations have not been studied. The objective of this study was to examine how prehabilitation can alter lung cancer immunity. METHODSNewly diagnosed lung cancer patients were referred to the prehabilitation clinic for preoperative personalized multimodal intervention (exercise training, nutritional optimization, and anxiety reduction) and blood samples were collected at baseline and surgery. Tumor samples were collected at surgery and compared to matched control samples from patients who did not receive prehabilitation. An animal model was used to study prehabilitation and tumor growth kinetics. RESULTSTwenty-eight lung cancer patients who underwent multimodal prehabilitation were included (McGill University Health Centre Research Ethics Board #2023-9005). After prehabilitation, patient-isolated peripheral blood mononuclear cells (PBMCs) showed significantly increased cytotoxicity against cancer cells (p < 0.0001) and significantly increased circulating natural killer (NK) cells in cohort (p = 0.0290) and paired analyses (p = 0.0312). Compared to matched controls, patients who received prehabilitation had significantly more intra-tumor NK cells (p = 0.0172). In vivo, we observed a significant increase in circulating NK cells (p = 0.0364) and slower tumor growth (p = 0.0396) with prehabilitation. When NK cells were depleted in prehabilitated mice, we observed a decrease in the protective effects of prehabilitation (p = 0.0314) and overall, we observed a significant correlation between circulating NK cells and reduced tumor volume (p = 0.0203, r = -0.5143). CONCLUSIONSMultimodal prehabilitation may play a role in antitumor immunity by increasing peripheral and tumour-infiltrating NK cells leading to a reduced cancer burden. Future studies on the protective effect of prehabilitation on postoperative immunity should be conducted.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration ofinflammatory immune cells in EGFR mutant lung tumors 92%
- Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer 92%
- Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells. 91%
Similar papers in this journal
- Dysregulation of lncRNA MALAT1 Contributes to Lung Cancer in African Americans by modulating the tumor immune microenvironment 93%
- High-intensity exercise is a risk factor for renal medullary carcinoma in individuals with sickle cell trait 91%
- Circulating Low Density Neutrophils Are Associated with Resistance to First-Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer 91%
Similar papers in this journal
- Pan-TREM-1 versus macrophage-restricted TREM-1 blockade in cancer and other inflammatory pathologies 92%
- Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer 92%
- Extracellular vesicle molecular signatures characterize metastatic dynamicity in ovarian cancer 90%
Similar papers in this journal
- Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors 93%
- NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model 92%
- Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking LAIR-collagen interaction 92%
Similar papers in this journal
- CHI3L1 Enhances Melanoma Lung Metastasis via Regulation of T cell Co-stimulators and CTLA-4/B7 Axis 92%
- Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy 92%
- Up-regulated tumor intrinsic growth potential and decreased immune function orchestrate the evolution of lung adenocarcinoma 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.